Corporate News Report – Merck & Co., Inc. (Ticker: MRK)
Merck & Co., Inc. (ticker MRK) closed the trading session on Wednesday, 21 October 2026 at USD 148.30 per share, a decline of 1.59 % from the previous session. The share price was USD 148.30 at 10:13 AM Central Europe. The market capitalization of Merck & is USD 354.4 billion. In the last 24 hours, roughly USD 1.5 billion worth of shares were traded on major exchanges, against a total supply of 2.5 billion shares.
The 200‑day simple moving average is USD 125.06. The all‑time high for the past 52 weeks was USD 156.92 (recorded on 25 August 2026). The 52‑week low was USD 82.01 (recorded on 4 November 2025). Since the end of the previous month, Merck & shares have declined 3.93 %.
Comparative Performance – 24 Hour Trading
| Company | Ticker | 24‑hour change | Current price (USD) | Market cap (USD bn) | P/E ratio |
|---|---|---|---|---|---|
| UnitedHealth Group | UNH | +1.36 % | 419.26 | 360.3 | 23.01 |
| Cisco Systems | CSCO | 0 % | 106.71 | 423.4 | 32.35 |
| Procter & Gamble | PG | –1.04 % | 159.32 | 370.1 | 23.98 |
| General Electric | GE | –0.81 % | 299.87 | 325.6 | 37.03 |
| Bank of America | BAC | –1.64 % | 50.64 | 354.7 | 12.24 |
UnitedHealth Group (UNH)
UnitedHealth Group shares rose 1.36 % to USD 419.26. The company’s market capitalization is USD 360.3 billion and the P/E ratio is 23.01. The upward movement coincided with a broader gain in the Dow Jones Industrial Average. Analysts cited UnitedHealth’s earnings update and guidance as a primary driver. Market sentiment was supported by a decline in crude‑oil prices, which lifted broader S&P 500 and Dow indices. Technology stocks, particularly 3M, added to the index’s performance, while the Nasdaq remained largely flat. Positive earnings reports from UnitedHealth and other healthcare peers helped offset concerns over artificial‑intelligence‑related volatility in technology.
Cisco Systems (CSCO)
Cisco Systems shares remained flat at USD 106.71. The company’s market capitalization is USD 423.4 billion and the P/E ratio is 32.35. Cisco was one of the weaker performers in the Dow Jones on Thursday. The company’s role in the broader observability and AI landscape was highlighted in a recent report, emphasizing Cisco’s investment in security and monitoring solutions that support enterprise‑wide AI deployments. The focus on agent observability reflects Cisco’s strategy to help customers deploy AI at scale while maintaining control over performance and expense.
Procter & Gamble (PG)
Procter & Gamble shares fell 1.04 % to USD 159.32. The company’s market capitalization is USD 370.1 billion and the P/E ratio is 23.98. Procter & Gamble announced plans to acquire supplement maker Thorne. The acquisition follows a broader industry trend of expanding into health‑related products, driven by increased consumer interest in dietary supplements among users of weight‑loss drugs such as GLP‑1 therapies. The move aligns with P&G’s strategy to diversify its portfolio and tap into the rising demand for wellness products. The Food and Drug Administration is considering new guidance on dietary ingredient safety, although regulatory attention remains divided over the pace and scope of potential reforms.
General Electric (GE)
General Electric shares declined 0.81 % to USD 299.87. The company’s market capitalization is USD 325.6 billion and the P/E ratio is 37.03. GE’s aerospace division reported mixed earnings: revenue growth exceeded expectations, but cash‑flow performance fell short of analysts’ forecasts. GE reiterated its full‑year outlook and raised guidance for commercial services revenue. The pace of engine deliveries to Boeing’s 787 programme remains a focus. GE HealthCare announced a global clinical evaluation of its StarGuide GX imaging system, partnering with institutions across five continents to advance quantitative and theranostic imaging. These initiatives reflect GE’s emphasis on strengthening its aviation engine business and expanding its medical imaging footprint amid cautious market sentiment.
Bank of America (BAC)
Bank of America shares fell 1.64 % to USD 50.64. The company’s market capitalization is USD 354.7 billion and the P/E ratio is 12.24. Bank of America Corp filed a free‑writing prospectus under SEC Rule 433 on 20 October 2026, outlining a forthcoming issue of market‑linked securities. The prospectus details a new class of securities whose returns depend on the performance of major equity indices. The issuer, BofA Finance LLC, is fully guaranteed by Bank of America Corp. The securities will carry a contingent coupon linked to the lowest‑performing underlying index. The filing provides key terms such as pricing, maturity, optional redemption dates, and coupon calculation, but does not disclose final pricing levels or terms. No commentary on market sentiment or company performance is included in the filing.
About Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare company that delivers health solutions through prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company markets its products directly and through joint ventures.
